1 / 16

Lymphatic filariasis

Lymphatic filariasis. Elephantiasis. Lymphatic filariasis is widespread and infects 120 million people. Lymphatic filariasis mainly affects tropical parts of the developing world. It is caused by the nematode Wuchereria bancrofti. responsible for 90% of the cases.

azuka
Download Presentation

Lymphatic filariasis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Lymphatic filariasis Elephantiasis

  2. Lymphatic filariasis is widespread and infects120 million people

  3. Lymphatic filariasis mainly affects tropical parts of the developing world.

  4. It is caused by the nematode Wuchereriabancrofti • responsible for 90% of the cases

  5. It is transmitted by mosquitos of several genera. • Culex • Anopheles • Aedes

  6. Humans and mosquitos are the 2 hosts of the parasites.

  7. There are three types of infection. • Asymptomatic • Acute • Chronic

  8. Acute filariasis involves local inflammation of skin, lymphatic vessels and lymph nodes.

  9. The chronic disease results in Lymphedema and Elephantiasis

  10. Several studies suggest that the body’s immune response to the pathogen causes the most harm.

  11. The only way to diagnose the disease is to identify microfilariae or adult worms in a patients blood using a microscope.

  12. The drug of choice in treating lymphatic filariasis is diethylcarbamazine (DEC).

  13. There is not thought to be a problem with resistance to DEC.

  14. WHO’s Global Programme to Eliminate Lymphatic Filariasis has greatly increased treatment and decreased transmission by 43%.

  15. There is a large social stigma against those with elephantiasis in many countries.

  16. References Eberhard, Mark L., Patrick J. Lammie, Charlotte M. Dickinson, and Jacqueline M. Roberts. "Evidence of Nonsusceptibility to Diethylcarbamazine in WucheriaBancrofti." The Journal of Infectious Diseases, May 1991. Web. 2 Apr. 2012. <http://www.jstor.org/stable/30132517?seq=1>. Heeren, Dan. "Elephantiasis." Davidson College, 2006. Web. 02 Apr. 2012. <http://www.bio.davidson.edu/courses/immunology/Students/spring2006/Heeren/ele ph.html>. King CL, Kumaraswami V, Poindexter RW, Kumari S, Jayara-man K, Alling DW, Ottesen EA, Nutman TB. “Immunologic tol-erance in lymphatic filariasis. Diminished parasite-specific T and B lymphocyte precursor frequency in the microfilaremic state.” J Clin Invest. 1992 May;89(5):1403–1410. "Lymphatic Filariasis: Causes." Better Medicine, 2011. Web. 02 Apr. 2012. <http://www.localhealth.com/article/lymphatic-filariasis/causes>. "Lymphatic Filariasis." WHO. Jan. 2012. Web. 02 Apr. 2012. <http://www.who.int/mediacentre/factsheets/fs102/en/>. Wynd, Shona, Wayne D. Melrose, David N. Durheim, Jaime Carron, and Margaret Gyapong. "Understanding the Community Impact of Lymphatic Filariasis: A Review of the Sociocultural Literature." WHO. June 2007. Web. 02 Apr. 2012. <http://www.who.int/bulletin/volumes/85/6/06-031047/en/index.html>.

More Related